The Food and Drug Administration announced March 20 that it had taken administrative action against four products across the pharmaceutical and personal care sectors.

The agency imposed a three-month suspension of manufacturing operations on a herbal patch product, citing violations of regulations governing management responsibilities between drug consignors and consignees.

The FDA also issued a one-month sales suspension for two antibiotic tablets for failing to update required drug identification markings.

In a separate action, the agency handed down a 15-day sales suspension for a line of bidet wet wipes for violating prohibitions on cosmetic sales.

The Food and Drug Administration announced March 20 that it had taken administrative actio …

April 2026: Major Regulatory Actions on Herbal Patches and Antibiotics in South Korea